June 25, 2024- Home infusion therapy offers numerous benefits for health systems. It allows for the delivery of high-quality care in the comfort of patients’ homes, reduces costs compared to hospital settings, and supports better patient outcomes. By embracing home infusion, health systems can improve care quality, patient satisfaction, and operational efficiency while also reducing expenses.
Keeping patients healthy and in their homes is a benefit and core component of patient-centric care. One area of significant expansion for health systems is the infusion therapy market. The home infusion therapy market is projected to grow from $11 billion in 2022 to more than $29 billion in 2032. “The rapid growth we are seeing in the home infusion therapy market is a significant opportunity for health systems to enhance patient care while managing their costs effectively,” said Katie Werner, Vice President of Infusion Therapy at McKesson Medical-Surgical, “and shifting infusion services into the home not only enhances patient comfort and adherence, but it also aligns with the growing need to lower expenses associated with hospital-based care.”